You are here: Home » International » News » Companies
Business Standard

In win for Indivior, US court blocks Dr Reddy's from selling generic drug

Indivior on Friday said the restrictions of the previous restraining order remain in place, preventing Dr. Reddy's from selling or importing its generic buprenorphine/naloxone


A US court has granted Indivior a preliminary injunction blocking India's Dr Reddy's Laboratories from selling cut-price versions of the British drugmaker's best-selling opioid addiction treatment in the United States, Indivior said on Friday. Indivior, a maker of opioid addiction treatments spun-off from Reckitt Benckiser in 2014, has been involved in a number of legal battles with generic drugmakers over their versions of its Suboxone Film . Indivior got a temporary restraining order against Dr.Reddy's in June, but the British firm saw the impact from a ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Sat, July 14 2018. 09:42 IST